Casi Pharmaceuticals Inc (CASI)
2.35 -0.08 (-3.29%) 11:34 ET [NASDAQ]
2.30 x 10 2.37 x 4
Realtime by (Cboe BZX)
2.30 x 10 2.37 x 4
Realtime - - (-) -
for Tue, Mar 18th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -26,259 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 3,741 | N/A |
| Accounts receivable | N/A | N/A | N/A | 3,422 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,149 | N/A |
| Other Working Capital | N/A | N/A | N/A | -6,830 | N/A |
| Other Operating Activity | 0 | -18,090 | 0 | 4,810 | 0 |
| Operating Cash Flow | $N/A | $-18,090 | $N/A | $-19,967 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 11,887 | N/A | -8,432 | N/A |
| PPE Investments | N/A | -42 | N/A | -204 | N/A |
| Purchase Sale Intangibles | N/A | 500 | N/A | -2,037 | N/A |
| Other Investing Activity | 0 | -132 | 0 | -1,037 | 0 |
| Investing Cash Flow | $N/A | $11,713 | $N/A | $-9,673 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 109 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -278 | N/A |
| Dividend Paid | N/A | -721 | N/A | -738 | N/A |
| Financing Cash Flow | $N/A | $-721 | $N/A | $-907 | $N/A |
| Exchange Rate Effect | N/A | -452 | N/A | 518 | N/A |
| Beginning Cash Position | N/A | 17,083 | N/A | 47,112 | N/A |
| End Cash Position | N/A | 9,533 | N/A | 17,083 | N/A |
| Net Cash Flow | $N/A | $-7,550 | $N/A | $-30,029 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -18,090 | N/A | -19,967 | N/A |
| Capital Expenditure | N/A | -42 | N/A | -204 | N/A |
| Free Cash Flow | 0 | -18,132 | 0 | -20,171 | 0 |